Perform Another (Advanced) Search

1.  CenterWatch: New Medical Therapies in Disease Category (107), Obesity
...0479) May 15, 2006 Vivus issued positive results of a phase II trial of Qnexa (phentermine/topiramate) for the treatment of obesity. This 4-arm, double-blind, randomized, placebo-controlled study ...
...patients at the Duke University Medical Center; subjects received Qnexa, approved control therapy with either phentermine or topiramate alone, or placebo. Trial data indicated that treatment with Qnexa produced significantly greater ...
View Page

2.  CenterWatch: New Medical Therapies in Disease Category (603), Diabetes Mellitus, Type 2
...percent) or high HbA1c (>8.0-12.0 percent). The subjects received Qnexa (15 mg phentermine/100 mg topiramate) or placebo. The primary endpoint was change in glycemic control as reflected ...
View Page